GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of what would you tell week-1 you about reimbursement — 56 comments in the full submission. View in context.
4.6k
c/glp1eu·submitted 1 year ago by u/greta_nilsen

what would you tell week-1 you about reimbursement

PSAbranch of 9 comments

Genuinely asking, not being difficult. Everyone in c/orforglipron repeats that prescription is important. I believe it, but I have never seen anyone show why, and when I search I get 10 threads of people agreeing with each other. Is there a paper? Is there a measurement? Or is this one of those things that is true…

Read the full submission and all 56 comments →

This branch

9 comments, started 1 year ago
u/amara_haddad276 points·1 year ago

pharmacy stock varies by country and season

replysharereportpermalink
u/tove_ogunleye213 points·1 year ago

pharmacy stock varies by country and season

Yes, exactly this, and it is the bit that took me 27 weeks to accept.

replysharereportpermalink
u/viktor_nkemelu50 points·1 year ago

tag your country in the title, bare EU gets a template

replysharereportpermalink
u/spain_receta13 points·1 year ago

reimbursement costs in New Zealand this month

replysharereportpermalink
u/greta_nilsenOP35 points·1 year ago

New Zealand here. Waited 18 months on a list, gave up, went private, and the total cost was roughly what I expected.

replysharereportpermalink
load more comments (4) →

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.